Materials and Methods
Mice. All Virus Inoculation. Under anesthesia, 0.05 ml of the virus preparation was inoculated into each lobe of the thymus of 3-to 6-wk-old mice.
Absorption Studies. The expression of H-2D and H-2K antigens in normal and RadLVinfected thymocytes was determined as previously described (2) by measuring the ability of these cells to absorb appropriate alloantisera.
asS-Methionine Labeling of Lymphocytes and One-Dimensional Sodium Dodecyl-Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) Analyses. Animals were killed by cervical dislocation and their
spleens, or solid tumors growing intraperitoneally excised and placed in phosphate-buffered saline (PBS). Single cell suspensions were prepared by gentle teasing and pipetting. Labeling with 35S-methionine and extraction with 0.5% NP-40 was done as previously described (4). The cell lysate was then centrifuged at 100,000 g for 1 h. The supernate was aliquoted and stored at -70°C until further use. For immunoprecipitation portions from 5 × 106 cells were cleared of labeled immunoglobulins with goat anti-mouse Ig (GAMIG) and carrier normal mouse serum (NMS) at equivalence. The resulting precipitate was removed by centrifugation at 8,000 rpm for 20 min. The supernate was then incubated at 37°C for 30 min with specific or control antiserum. GAMIG was then added again and the samples incubated at 4°C overnight. The precipitate was then collected by centrifugation at 8,000 rpm for 20 min, washed at least four times in 1% Triton-X-100-1% deoxycholate in PBS, pH 7.4, dried, and then subjected to SDS-PAGE according to the method of Witte and Weissman (5).
Cultures. All RadLV-transformed tissue culture lines were adapted from RadLV infected, leukemic animals. Lymphoid tissues were removed and placed in culture at a concentration of 2-4 X 106 cells/ml. Cultures were split and fed after 2 d. Afterwards, daily observations of the cultures were carried out to feed the cells as required while always keeping a portion of the conditioned growth media present. The first signs of successful adaptation of the cultures was the formation of an epithelial sheet with clusters of round cells throughout. After several weeks, the latter cells became autonomous and the feeder-layer unnecessary. Success rates in adapting lymphoid tumors and culture varied between 30 and 60'7~.
BW5147 cells were originally obtained from the Salk Institute, San Diego, Calif. and have been maintained independently since 1975. Their karyotype and growth conditions have been described previously (6) .
Preparation of Effector Cells, '~Cr-Labeled Target Cells, and Assqy for CeU-Mediated C~totoxicity.
Cells were prepared and cell-mediated lympholysis activity measured as previously described (6) , except that cells used for this test were grown in RPMI-1640 with 25 mM Hepes (Grand Island Biological Co., Grand Island, N. Y.). The assay was also carried out in RPMI-1640. Special care was given to the use of fresh Na '~lCr (Amersham Corp., Arlington Heights, Ill.) for labeling target cells. Incubation times varied from 4 to 12 h.
Antiserum and Complement-Mediated Cytotoxicity. Spleen cells were prepared with gentle teasing in Dulbecco's modified Eagle's medium (DMEM) and 5~7~ FCS, centrifuged, counted, and aliquoted in tubes at a concentration of 20 × 10~/tube. They were then centrifuged and resuspended in 1 ml of 1/5 dilution of the appropriate antiserum or control serum (diluted in DMEM + 5% fetal calf serum [FCS] ). After 30 rain at room temperature, they were spun down, and resuspended in 3 ml of 1/9 dilution (diluted in DMEM) of agarose-adsorbed rabbit complement. After 45 min incubation at 37°C, cells were pooled (if more than one tube of 20 x 106 cells was treated with a given serum), counted to assess percent cytotoxicity, centrifuged, washed three times, and recounted.
Results

Resistance to Syngeneic RadLV Tumor Cells Mimics H-2D Control of RadLV-Induced
Neoplasm. It has been previously shown (19) . Because H-2 antigens seem to be required for cell-mediated killing (7) (8) (9) , difficulties with the in vitro assay for CMI may have resulted from the use of tissue culture adapted RadLV transformed cells as targets. Therefore, an attempt was made to determine whether H-2 modulation occurred if these cells were grown in vivo in normal, nonleukemic animals.
When syngeneic RadLV transformed cells are injected intraperitoneally into resistant and susceptible animals, they do not grow as an ascites tumor. In susceptible mice, tumor cells initially invade the spleen and then multiply in other lymphatic organs. However, in resistant mice tumor cells grow in the spleen and lymphatic organs to a lesser extent and predominantly as a solid peritoneal tumor. Tumor cells multiply slower in resistant than in susceptible mice, and are often completely eliminated after some initial growth in the former animals. rate as killing by anti-D s, but begins to kill a larger percentage of the cells after day 9. The same pattern can be observed in (B10.G × B10.S(7R)) F1 mice. However, the percentage of spleen cells of these mice that can be killed with anti-D q after day 9 is much higher than the percentage of spleen cells that can be killed with this serum for (B10.G X B10.S) F1 mice. These findings strongly suggest that phenotypically H-2-negative tumor cells can proliferate in vivo to give rise to tumor cells which express the appropriate H-2 antigens. However, the above experimental procedures involve simultaneous comparison of killing by several antisera; and is less desirable than more direct measurements. Fortunately, RadLV transformed cells often grow as solid peritoneal tumors in resistant mice. These tumors are composed almost entirely of donor cells and few host cells. Because little contamination, if any, by host cells is encountered, direct assay of H-2 re-expression can be carried out on the growing tumor cells. By use of two additional techniques, it has been possible to demonstrate directly that H-2 antigen re-expression occurs for cells derived from the injected cells, as they multiply in the peritoneal cavity. For example, when a fixed number of tumor cells is recovered and tested at various intervals after inoculation, their anti-H-2 absorbing capacity gradually increases (data not shown). Likewise, the ability of these cells to bind H-2 antibodies, as detected by a two-step radioimmunoassay, markedly increases as their exposure to the in vivo environment lengthens (data not shown).
As a further check, the re-expressed antigens were compared by SDS-PAGE with normal spleen cellular H-2 antigens. Spleen cells, tissue culture adapted B 10.T(6R), and in vivo grown B 10.T(6R) cells from a solid peritoneal tumor were incubated with 35S-methionine for 3 h. After this step, immunoprecipitation of NP-40 lysates was done with H-2 alloantisera and goat anti-mouse IgG, and the resulting precipitates were submitted to SDS-PAGE analysis and compared with one another (Fig. 2) . ,'ere incubated in I)MEM for 3 h with :~SS-methionine. After this step, inmmnoprecipitation of NP-4ll tysates were done with 11-2 alhmntisera and g, oal anti+ mouse lgG, and the resulting precipitate sul)mitted to SI)S-PAGE analysis. not only fail to express H-2 antigens as detected by absorption analysis (2), but also cannot be shown to synthesize these antigens by the present scheme. It is possible that synthesis of these antigens does occur, yet degradation takes place immediately after the nascent polypeptide chains are formed, yielding no detectable product, or that a nonantigenic polypeptide precursor is formed and remains uncleaved. Panel C is a control spleen preparation. Tile usual 45,000 and 12,000 tool wt pattern, associated with H-2 antigens and tile mouse analogue of fi2 microglobulin, respectively, is obtained. The CMI response appears to be specific because neither BW5147 cells (H-2 k) nor normal spleen cells (H-2 a) are lysed by the effector cells. They also fail to lyse EL-4 (H-2Db), which were derived from a C57BL/6 mouse (data not shown).
A technically more difficult experiment is shown in Fig. 4 . 
Resistant Mice Develop Greater Numbers of Effector Cells When Inoculated with
Discussion
The findings presented in this report indicate that the genetics of resistance to syngeneic RadLV-induced tumor cells are identical to H-2D control of RadLVinduced leukemogenesis. These findings are suggestive of a role for H-2D gene(s) at some point after malignancy has ensued. This type of resistance would be expected to be immunological. Several observations are in accord with this expectation. First, CMI against RadLV transformed or infected cells can be detected with ease when H-2-positive target cells are used in the cell-mediated lympholysis (CML) assay. Second, resistant mice develop greater numbers of effector cells when infected with RadLV than do susceptible mice. Third, the previous observation that rapid increases in cellular synthesis and cell-surface expression of H-2 antigens are detectable immediately after virus inoculation has suggested that altered expression of H-2 antigens may play a significant role in the mechanism(s) of host defense to virus infection. This concept is strengthened by the findings documented in Fig. 6 ; namely injection of normal (uninfected) thymocytes into syngeneic recipients of resistant or susceptible Preliminary experiments indicate that transfer of thymocytes infected with RadLV for a short time (e.g. 3 wk), from resistant or susceptible mice, into irradiated adult, syngeneic F1 mice leads to death from tumorigenesis in a relatively short time (D. Meruelo, unpublished observations). It is unlikely that such death results from the induction of leukemia by virus present in transformed cells, because the progress of disease is too rapid, and RadLV does not lead to leukemia when injected into adult mice. The likely conclusion is that preleukemic cells exist in the thymus of both resistant and susceptible mice and that transfer to the irradiated host environment permits such cells to escape the immunological control that prevents their growth in unirradiated, resistant mice.
It has been shown here that the failure to detect differences in anti-RadLV CMI between resistant and susceptible animals was due to the absence of H-2 determinants on the target cells used. A change in phenotypic expression from H-2 + to H-2-accompanies overt leukemia and can be reversed by in vivo passage by RadLV transformed cells through healthy, syngeneic recipients. H-2 antigen modulation has been previously observed by Boyse et al. (10, I1) . In these studies, an inverse relationship was observed in cells undergoing antigenic modulation between the expression of TL and H-2D antigens. It has been suggested that TL antigens derived from a viral genome integrated in chromosome 17 (12) . In this regard, two observations are relevant. First, tissue culture adapted, RadLV-transformed cell lines produce substantial levels of thymotropic virus, and are H-2 negative, but after in vivo passage these cells show markedly reduced virus production and full expression of H-2 antigens. In addition, it has been shown (2) that from the early stages of the disease, there is an inverse relationship between viral and H-2 antigen expression. A reduction in virus production could be explained by antibody or cellular elimination or reduction of RadLV. However, there is some evidence that 11-21) gene(s) regulate virus production (13) . In view of these findings, the notion that a viral genome is integrated in chromosome 17 is provocative and should be pursued further.
The data presented here are of further relevance in view of two established observations regarding type-C RNA virus-induced leukemia. First, it is well known that murine type-C RNA virus must be inoculated in neonatal or very young mice for successful leukemogenesis. Second, a great many of these viruses exhibit preferential tropism for the thymus. This is best exemplified by RadLV, which is usually injected intrathymically for optimal leukemia incidence, and causes a disease which has as principal characteristic the development of thymomas (14) . In view of the importance of H-2 antigens for T-cell killing (7-9), these two facts could be explained if virus infection of neonatal cells or thymocytes (low H-2 bearing cells) is more successful than infection of adult or mature cells because cells having high levels of H-2 and virus antigen trigger strong CMI and become rapidly eliminated.
The very rapid and dramatic increases in expression of H-2 antigens on thymocytes of resistant mice immediately after virus injection may represent an evolutionally developed defense mechanism. This mechanism of defense would be expected to be of particular importance because it occurs in the thymus. Zinkernagel et al. (15) have recently provided evidence that the thymus is the site where cell-cell recognition is learned.
There is one observation that cannot be completely explained by these results. This is the finding that F1 mice of resistant 1t-2 type survive a tumor inoculation longer than do F1 mice of susceptible H-2 genotype. Because tumor cells growing in both Fls appear to re-express H-2 antigens after a few days of in vivo growth, the inability of susceptible mice to reject the tumor cells and the ability of resistant mice to, at least, survive longer, raise the possibility that an Ir gene importarit in resistance to RadLV-induced neoplasia may be operative in the H-2Dregion. If so, H-2 q/a of H-28/a F1 mice would be high responders, whereas 11-2 ~/~ F1 would be low responders. This observation requires additional study.
The present studies need to be expanded to encompass other type-C RNA viruses. Some investigators have reported similar effects on H-2 antigen expression by Friend (16) and AKR viruses (17) , but a more detailed study is required. If similar changes in HLA expression at various stages of leukemogenesis could be demonstrated (suggested by reported instances in which investigators were unable to type leukemic cells [18] ), these findings would have very significant clinical implications.
Summary
Resistance to neoplasia caused by radiation-induced leukemia virus (RadLV) is mediated by gene(s) in the H-2D region of the major histocompatibility complex. The previous observation that rapid increases in cellular synthesis and cell-surface expression of H-2 antigens are detectable immediately after virus inoculation has suggested that altered expression of H-2 antigens may play a significant role in the mechanism(s) of host defense to virus infection. This concept is supported by the following observations. First, cell-mediated immunity against RadLV transformed or infected cells can be detected with ease when H-2-positive target cells are used in the cell-mediated lympholysis (CML) assay. (Although RadLV transformed cells obtained from overtly leukemic animals and maintained in tissue culture are H-2 negative, these cells can regain their H-2 phenotype by in vivo passage in normal animals. The H-2-negative cells are poor targets in a CML assay.) Second, resistant mice develop greater numbers of effectors when infected with RadLV than do susceptible mice. Third, injection of normal (uninfected) thymocytes into syngeneic recipients of resistant or susceptible H-2 type does not stimulate a CML response. However, injection of RadLV infected thymocytes from resistant mice produces a vigorous CMI response, and such thymocytes elicit the strongest response at a time when both H-2 and viral antigen expression is elevated. By contrast, injection of infected thymocytes from susceptible mice, which express viral antigens, but low levels of H-2 antigens, does not stimulate a CML reaction.
These findings may explain the easier induction of leukemia found by many investigators when virus is inoculated into neonatal mice and the preferential thymus tropism of some oncogenic type-C RNA virus. Cells expressing very low levels of H-2, such as thymocytes, may serve as permissive targets for virus infection because they lack an important component (H-2 antigens) of the dual or altered recognition signal required to trigger a defensive host immune response.
